Archive | Richmond Pharmacology

Celebrating Clinical Trials Day 2023

Futureproofing early phase clinical research for the next generation of investigators.

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

Unlocking the potential of data sharing

Richmond Pharmacology appoints Sandra Johnson as Director of Commercial Project Management

How telemonitoring can revolutionise the way we treat patients – Tom York

Samarjit Singh promoted to New Director of Clinical Operations

Transforming clinical trials to accelerate drug development – Keith Berelowitz

Clinical trials: how taking the pills can pay those bills.

Clinical trials and the patient perspective

NTLA-2001 demonstrates positive results for Intellia Therapeutics and Regeneron Pharmaceuticals

How the innovative use of data is transforming clinical research

The future of clinical workforce training programmes, an exclusive interview with MedCity

Richmond Pharmacology’s Dr Emma Akuffo joins fellow EUCROF task force members as a finalist at TOPRA Awards 2021

Developing talent in the fast-changing clinical research environment

Dr Ulrike Lorch joins the leadership team at the Faculty of Human Pharmacology

Focal epilepsy treatment progresses following positive Phase IIb results

The future of new medicine development and first-in-human studies

Making gains in drug development

Inclisirin hailed as a 'gamechanger' gains approval for NHS patients

Richmond Pharmacology listed in the Alantra Pharma Fast 50

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

What 20 years of clinical research has taught us about our industry and the future of drug development

Do we still need challenge trials with COVID-19?

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

A new era for UK-Japanese scientific relations

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

Richmond Pharmacology supports Codiak BioSciences in the development of a new medicine to help patients with cutaneous T cell lymphoma.

Contributing to our community in 2020

Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients

Marking a milestone for gene editing

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

Richmond Pharmacology supports ReViral with the development of Sisunatovir

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

Dr Jorg Taubel, CEO of Richmond Pharmacology, features on the PM Live website, discussing clincial trials and COVID-19

COVID-19 – External Monitoring Guidelines

First transdermal patch to treat schizophrenia hits market

Statement: COVID-19

Richmond Pharmacology supporting clinical facilities in Nicaragua

Charitable Contributions in 2019

Richmond Pharmacology to provide Immediate Life Support (ILS) Courses

Echocardiography Course undertaken at Richmond Pharmacology

Richmond Pharmacology, Medical Director, Dr Lorch welcomes new Clinical Pharmacology Apprentice scheme

Dr Arezina article published in GMP review

Richmond Pharmacology Confirm event with the Department of International Trade

Officially an ILS Resuscitation Council Course Centre

Dr Jorg Taubel attending ACCP in San Diego

DIA, Chicago 2017

Local volunteers play valuable role in developing new medicines in Croydon

Richmond Pharmacology presents latest Thorough QT study at the ASCPT 2014 Annual Meeting

AGAH Annual Meeting 2014 Mitigating risks in early medicines development

A volunteer panel the size of a city...

Joint Conference of European Human Pharmacological Societies CLUB PHASE I (France), AGAH (Germany), BAPU (Belgium), AHPPI (UK)

RPL presents further confirmation of the food effect on the QTc interval

Cardiac Safety: Key issues and best practice for Thorough QT Studies and Intensive Phase I QT Studies

Richmond Pharmacology presents Improving Clinical Trial Design at the BAPU 4th 2-yearly Symposium 2012

Richmond Pharmacology presents further QT insulin data next month in San Diego!

London 2012 Olympics: British Business Embassy launches today

Richmond Pharmacologys latest research on the effect of food on the QT interval Presented at the 6th European Congress of Pharmacology 2012

DIA 3rd Cardiac Safety Workshop Explores the Future of the TQT Study And Issues Surrounding the Conduct and Analysis of TQT Studies in Japan

Cardiovascular Safety and State-of-the-art Development Issues 2012: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

QT Assessment in Early Clinical Development Can the Predictive Value be Enhanced to be Similar to That of a TQT study?

Further data to be presented at The 32nd Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT)

Richmond Pharmacology enhances its established GE MUSE platform with the State-of-the-art Mortara 12-lead telemetry setup

Accelerating Early Phase Clinical Development in the UK:

RPL recently attended the 10th Annual Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT)

Richmond Pharmacology welcomes you to attend the ACCP 40th Annual Meeting, taking place 11th to 13th Sept, 2011

Good data is essential for a successful study. Whilst analysis is important, standardisation in the clinic is imperative.

Join Richmond Pharamcology at the 2nd DIA Cardiac Safety Workshop in Japan for our latest TQT Analysis in Japanese and Caucasian Volunteers

Richmond Pharmacology Celebrates 10 Years at the Henley Royal Regatta

Join Richmond Pharmacology at this year's 10th Annual Congress of the European Association for Clinical Pharmacology

Cardiovascular Safety in Drug Development: State-of-the-Art Assessments

TQT Analysis in Japanese and Caucasian Volunteers

Imported item 88

112th ASCPT Annual Meeting

Richmond Pharmacology will be attending the 5th Annual Cardiovascular Risk Assessment Summit taking place 26th to 27th January 2011 in Alexandria, Virginia.

Announcement on Japanese Representation Business Agreement between Richmond Pharmacology and ACRONET Corporation.

Richmond Pharmacology will be attending the 4th DIA European Cardiac Safety Conference taking place later this month in Nice from 25th to 26th October 2010.

Save the date next month and RP

Richmond Pharmacology's Volunteer Database Exceeds 100,000 Volunteer Registration Records

Richmond Pharmacology (RPL) will be attending this month's 22nd Annual DIA EuroMeeting, taking place 8-10 March 2010 in Monaco.

Richmond Pharmacology is proud to announce that it will be hosting the AHPPI Winter Meeting early next month.

Richmond Pharmacology, the 1st Early Phase CRO to receive MHRA Standard and Supplementary Accreditation for 2 hospital based Clinical Trial Centres.

Richmond Pharmacology take part in the MS Society Wheel and Walk: A great Success for all!

Richmond team to take part in the MS Society Wheel & Walk at Windsor Great Park

Improving Safety in Phase I Trials - Planning Your Early Phase Development?

Safety and Risk Management in Translational Medicine

Calling all Clinical Phase I Outsourcing Professionals!

October Newsletter

6th AGAH Dermatological Product Development Workshop Highlights

High Court rules that Health Research Authority acted unlawfully over trial transparency

2nd Cardiac Safety Conference

The reference book you cannot live without.

Community Conscience

2007's most comprehensive QT & Safety Pharmacology Strategy Congress takes place in just under two weeks!

Joint AHPPI and ICR Meeting

Accreditation of Phase I units in the UK

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Careers at Richmond

We are on the lookout for people who love what they do, strive for excellence and who want to make a difference.

Our Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Celebrating Clinical Trials Day 2023

May 19, 2023

This year, we will be celebrating Clinical Trials Day alongside our workforce, sponsors and industry colleagues.

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023

Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.

Events

HFA Annual Meeting 2023

Saturday 20th May 2023 - Tuesday 23rd May 2023

Join Dr Taubel at the HFA Annual Meeting in Prague